Bluebird Bio

Bluebird Bio
Develops gene therapies for severe genetic disorders.
Gene Therapy
Biotechnology
Clinical Research
Genetic Engineering
Cell Biology
Bluebird Bioの求人
求人0件
現在募集中の求人はありません
製品・サービス

Zynteglo
Gene Therapy
BB
bb1111
Gene Therapy

Skysona
Gene Therapy
LE
LentiGlobin
Gene Therapy Platform
BB
bb2121 (ide-cel)
Cell Therapy

Gene Therapy Manufacturing Services
Manufacturing Services

bb21217
CAR-T Cell Therapy
MA
Manufacturing Services
Services
LE
Lenti-D
Gene Therapy
類似企業

Intellia
Focused on developing novel, potentially curative therapeutics leveraging CRISPR-based technologies.
Cambridge, Middlesex County
201-500名
Public
企業価値 $1.2B
3件の求人

Sarepta
We are focused on the development of precision genetic medicines to treat rare neuromuscular and central nervous system diseases. Learn more about Sarepta.
Cambridge, Massachusetts
501-1,000名
Public
企業価値 $1.8B
11件の求人
Pfizer
We integrate environment, health, and safety (EHS) into how we run our business to ensure that management of risk and regulatory compliance are overseen at…
New York City, New York
10,001+名
Public
企業価値 $280B
285件の求人
Boston Scientific
Boston Scientific is dedicated to transforming lives through innovative medical solutions that improve the health of patients around the world.
Marlborough, Massachusetts
10,001+名
Public
企業価値 $58B
1,499件の求人

Grail
GRAIL is a healthcare company pioneering new technologies to advance early cancer detection. Discover our mission to detect cancer early, when it can be cured.
Menlo Park, California founded
201-500名
Private
企業価値 $3.2B
30件の求人
最新情報
All
X
News
HN
YouTube
Bluebird bio Inc (BLUE) Key Financial Ratios – Valuation, Profitability & More - Value Research
Value Research
News
·
1週間前
Bluebird bio Inc (BLUE) Peer Comparison – Compare with Others - Value Research
Value Research
News
·
1週間前
Bluebird Bio - 2026 Funding Rounds & List of Investors - Tracxn
Tracxn
News
·
1ヶ月前
bluebird bio stock falls after reverse split and capital raise reshape the balance sheet - Ad-hoc-news.de
Ad-hoc-news.de
News
·
1ヶ月前
Genetix turns profitable after acquiring bluebird bio assets from financial distress - The Business Journals
The Business Journals
News
·
2ヶ月前
もっと見る (残り6件)
閲覧数
2
応募クリック
0
模擬応募
0
スクラップ
0
レビュー
3.8
10件のレビュー
ワークライフバランス
3.2
報酬
3.5
企業文化
4.1
キャリア
2.8
経営陣
2.5
65%
知人への推奨率
良い点
Supportive team and colleagues
Good work-life balance and flexible hours
Cutting-edge technology and interesting projects
改善点
Poor management and lack of direction
Limited career advancement and slow promotions
High pressure and demanding work
給与レンジ
54件のデータ
Director
3件のレポート
-
年収総額
基本給
$214,225
ストック
-
連絡先・所在地